We are actively working with researchers at private institutions, universities, and corporations to put the power of the NeXosome platform to work to enable new diagnostic solutions within the maternal fetal medicine field.  Please contact us if you are interested in talking with us about partnership opportunities (info@nxprenatal.com).

 

Clinical Partners
Physicians and clinical practices interested in participating in our clinical studies

 

Research Partners
We can facilitate joint exosome-based research with our leading, quality controlled tools

 

Commercial Partners
License and distribution partners for Platform and Product applications within MFM field

 

With respect to our collaborative and sponsored research programs, the company implements a cap of 23 percent on the percentage of funds that can be provided to universities and institutions to cover Facilities and Administrative (F&A) costs, often referred to as indirect costs.  We understand that these indirect costs cover a portion of the university’s infrastructure and operational costs related to research;  we are pleased to have the opportunity to subsidize research conducted under collaborative and sponsored research studies with our partners.